Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Clinical trial NCT03656562 · COMPLETED
Trial details
- NCT number
- NCT03656562
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2022-07-27
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.